Cite

MLA Citation

    Ian D. Pavord et al.. “Response to mepolizumab treatment is sustained across 4-weekly dosing periods.” ERJ open research, vol. 6, no. 3, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100172000026.0x000044
  
Back to record